Father-of-four Elliot Pfebve took part in a trial for cancer vaccines.
A man with bowel cancer has become the first person in England to be treated with a personalised jab for the disease on the NHS.Officials said thousands more people are expected to be recruited to take part in vaccine trials for various forms of cancer in the coming years as part of a new scheme.
The vaccine was created using mRNA technology and is being jointly developed by biopharmaceutical companies BioNTech and Genentech. We know that even after a successful operation, cancers can sometimes return because a few cancer cells are left in the body, but using a vaccine to target those remaining cells may be a way to stop this happening
It forms part of NHS England’s Cancer Vaccine Launch Pad, which is working to fast-track patients to get vaccines at the earliest opportunity. Professor Peter Johnson, national clinical director for cancer at the NHS, said: “We know that even after a successful operation, cancers can sometimes return because a few cancer cells are left in the body, but using a vaccine to target those remaining cells may be a way to stop this happening.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Bowel cancer patient first in England to have personalised jab to fight diseaseFather-of-four Elliot Pfebve took part in a trial for cancer vaccines.
続きを読む »
Bowel cancer patient first in England to have personalised jab to fight diseaseFather-of-four Elliot Pfebve took part in a trial for cancer vaccines.
続きを読む »
Martin Kemp, 62, fears he has 'ten years left to live'The Spandau Ballet father is the father to Capital FM presenter Roman Kemp
続きを読む »
Leeds to host Euro 2024 outdoor fanzoneEngland fans will be hoping to cheer England to Euro 2024 glory
続きを読む »
Drugs can reduce recurrence after bowel cancer surgery, new thesis suggestsA thesis at Umeå University shows that certain non-steroidal anti-inflammatory drugs, known as NSAIDs, can help patients who have undergone surgery for colorectal cancer. These patients suffer fewer recurrences of cancer and fewer leaks at the surgical site, so-called anastomotic leakage.
続きを読む »
Scientists propose therapeutic approach for inflammatory bowel diseaseIn a study published in Cell Host & Microbe, a research team has demonstrated the causal link between microbial factors and dysfunction of intestinal stem cells (ISCs) in colitis. On the basis of this mechanism, they proposed a possible approach to restore ISC function in colitis.
続きを読む »